Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults

The addition of blinatumomab to consolidation chemotherapy in adults with B-cell precursor acute lymphoblastic leukemia who had minimal residual disease–negative status after treatment improved overall and relapse-free survival.

​   The New England Journal of Medicine: Search Results in Hematology/Oncology